Breaking News, Promotions & Moves

Electra Therapeutics Names Kathy Dong President and CEO

Dong has more than 15 years of experience in corporate development, business operations, portfolio management, and product commercialization.

Electra Therapeutics, Inc., a clinical stage biotechnology company, appointed Kathy Dong, President and Chief Executive Officer. Dong succeeds Adam Rosenthal, who was co-founder and CEO of Electra. Rosenthal will continue to serve as a member of Electra’s board of directors and as CEO of Star Therapeutics, the company that spun out Electra. Dong has more than 15 years of experience in corporate development, business operations, portfolio management, and product commercialization. Previously, ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters